Dr Al Edwards of University of Reading will talk about one of his major areas of research, which focuses on developing simple devices for portable, low-cost, point of care bioassay testing exploiting a novel melt-extruded microstructured material called Micro Capillary Film (MCF).
His current work has two objectives:
Firstly, developing a range of devices that can perform rapid tests using standard immunoassay chemistry in different settings, ranging from fully automated bedside testing, to simple, portable manually operated devices for testing in the field that can then be read using simple optical readers such as a smartphone camera.
Secondly, MCF is especially suitable for performing the many and varied tests that are used to detect and identify microorganisms such as bacterial pathogens. His team is therefore pioneering the miniaturisation of microbiology tests using MCF.
In 2012 Dr Edwards co-founded Capillary Film Technology Ltd, a healthtech startup company that aims to commercialise MCF immunoassay technology for diagnostic applications. CFT's lead product is a fully automated rapid test platform, which will initially allow faster heart attack diagnostics.
For further information please contact:
markscudamore@blueyonder.co.uk
His current work has two objectives:
Firstly, developing a range of devices that can perform rapid tests using standard immunoassay chemistry in different settings, ranging from fully automated bedside testing, to simple, portable manually operated devices for testing in the field that can then be read using simple optical readers such as a smartphone camera.
Secondly, MCF is especially suitable for performing the many and varied tests that are used to detect and identify microorganisms such as bacterial pathogens. His team is therefore pioneering the miniaturisation of microbiology tests using MCF.
In 2012 Dr Edwards co-founded Capillary Film Technology Ltd, a healthtech startup company that aims to commercialise MCF immunoassay technology for diagnostic applications. CFT's lead product is a fully automated rapid test platform, which will initially allow faster heart attack diagnostics.
For further information please contact:
markscudamore@blueyonder.co.uk
